August, 2017 | HAEMATO AG

HAEMATO Group

Group
News
Investor Relations
Contact

Select Page

Interim report second quarter 2017

by HAEMATO AG | Aug 31, 2017 | Investor News

HAEMATO AG is a listed pharmaceutical company focusing on the growth markets of patent-free and patent-protected drugs primarily in the high-price indicative areas of oncology and HIV as well as in the areas of rheumatism, neurology and cardiac, circulatory diseases....

Archiv

March 2020
November 2019
August 2019
May 2019
March 2019
November 2018
August 2018
July 2018
May 2018
March 2018
November 2017
August 2017
July 2017
May 2017
January 2017

This website uses cookies to provide you with the best browsing experience.

Find out more or adjust your settings.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

disable

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

disable

Please enable Strictly Necessary Cookies first so that we can save your preferences!

3rd Party Cookies

More information about our Cookie Policy

Interim report second quarter 2017

Categories

Archiv